Dr. Marston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500Fax+1 617-975-0990
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2016 - 2020
- University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 2015 - 2016
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2015
- University of Minnesota Medical SchoolClass of 2012
Certifications & Licensure
- CA State Medical License 2014 - Present
- MA State Medical License 2016 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Polygenic Risk and the Progression of High-Risk Coronary Plaque.Nicholas A Marston
JACC. Cardiovascular Imaging. 2024-12-01 - 1 citationsRole of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association.Daniel E Soffer, Nicholas A Marston, Kevin C Maki, Terry A Jacobson, Vera A Bittner
Journal of Clinical Lipidology. 2024-09-05 - 1 citationsReductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial.Andre Zimerman, Stephen D Wiviott, Jeong-Gun Park, Sabina A Murphy, Xinhui Ran
European Journal of Preventive Cardiology. 2024-08-09
Journal Articles
- Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesNicholas A Marston, Marc P Bonaca, Petr Jarolim, Deepak L Bhatt, Stephen D Wiviott, Eugene Braunwald, Marc S Sabatine, JAMA Cardiology
Authored Content
- Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesAugust 2020
Press Mentions
- ApoB Can Be High, Risky for ASCVD Even When LDL’s NormalJune 17th, 2024
- ApoB Gains Ground as Best Lipid Predictor of MI RiskNovember 22nd, 2021
- No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIERSeptember 2nd, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: